Janus Henderson Group PLC Atai Life Sciences N.V. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.27 - $2.28 $5 - $9	-4 Reduced 0.01%	61,391 $79,000
Q2 2023 Aug 14, 2023	SELL	$1.44 - $2.19 $162 - $247	-113 Reduced 0.18%	61,395 $105,000
Q1 2023 May 15, 2023	BUY	$1.17 - $2.7 $34,595 - $79,836	29,569 Added 92.58%	61,508 $111,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $96,775 - $169,915	31,939 New	31,939 $116,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $234M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.